Clinical Trials Logo
  1. Home
  2. Steatohepatitis, Nonalcoholic
  3. NCT04080947

The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis

Steatohepatitis, Nonalcoholic Clinical Trial

Official title:
The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Clinical Trial Summary

The aim of the current study is to evaluate the safety and efficay of Montelukast in treatment of patients with fatty liver disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04080947
Study type Interventional
Source Sadat City University
Contact
Status Completed
Phase Phase 1/Phase 2
Start date August 1, 2019
Completion date March 15, 2022
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04861012 - Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt N/A
Completed NCT04932512 - A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224 Phase 2
Completed NCT03915002 - Integrated Approaches for Identifying Molecular Targets in Liver Disease
Recruiting NCT06400771 - Safety of DNP007 in Healthy Subjects Phase 1
Recruiting NCT06302049 - Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis Phase 1/Phase 2
Recruiting NCT04707651 - Formula Diet Treatment for NASH Patients. N/A
Terminated NCT04175392 - Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis Phase 1/Phase 2
Recruiting NCT04785937 - Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients N/A
Active, not recruiting NCT05946330 - Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). N/A
Terminated NCT04284371 - The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients